Connection

Xiaoming Yang to Antibodies, Viral

Back to Details
This is a "connection" page, showing publications Xiaoming Yang has written about Antibodies, Viral.
Xiaoming Yang
Connection Strength
0.184
Antibodies, Viral
  1. Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan. Nat Commun. 2021 07 06; 12(1):4144.
    View in: PubMed
    Score: 0.090
  2. Molecular deconvolution of the neutralizing antibodies induced by an inactivated SARS-CoV-2 virus vaccine. Protein Cell. 2021 10; 12(10):818-823.
    View in: PubMed
    Score: 0.022
  3. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial. Lancet Infect Dis. 2021 01; 21(1):39-51.
    View in: PubMed
    Score: 0.022
  4. Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2. Cell. 2020 08 06; 182(3):713-721.e9.
    View in: PubMed
    Score: 0.021
  5. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci U S A. 2020 04 28; 117(17):9490-9496.
    View in: PubMed
    Score: 0.021
  6. Low toxicity and high immunogenicity of an inactivated vaccine candidate against COVID-19 in different animal models. Emerg Microbes Infect. 2020 Dec; 9(1):2606-2618.
    View in: PubMed
    Score: 0.005
  7. [An epidemiological study of rabies virus in domestic dogs, cats and wildlife and the immunogenicity study for rabies vaccines derived from different cell cultured virus strains]. Bing Du Xue Bao. 2007 Nov; 23(6):417-23.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.